Cargando…
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
Autores principales: | Rockett, Rebecca, Basile, Kerri, Maddocks, Susan, Fong, Winkie, Agius, Jessica E., Johnson-Mackinnon, Jessica, Arnott, Alicia, Chandra, Shona, Gall, Mailie, Draper, Jenny, Martinez, Elena, Sim, Eby M., Lee, Clement, Ngo, Christine, Ramsperger, Marc, Ginn, Andrew N., Wang, Qinning, Fennell, Michael, Ko, Danny, Lim, H. Ling, Gilroy, Nicky, O’Sullivan, Matthew V.N., Chen, Sharon C.-A., Kok, Jen, Dwyer, Dominic E., Sintchenko, Vitali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929376/ https://www.ncbi.nlm.nih.gov/pubmed/35263515 http://dx.doi.org/10.1056/NEJMc2120219 |
Ejemplares similares
-
SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture
por: Agius, Jessica E., et al.
Publicado: (2022) -
SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes
por: Fong, Winkie, et al.
Publicado: (2023) -
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
por: Rockett, Rebecca J., et al.
Publicado: (2022) -
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
por: Basile, Kerri, et al.
Publicado: (2022) -
Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity
por: Howard-Jones, Annaleise R, et al.
Publicado: (2023)